2021 annual financial data
Vistagen Therapeutics, Inc. 2021 Net margin
Vistagen Therapeutics, Inc. 2021 net margin with verified reported values.
Direct answer
Net margin was -1,646.09%.
Operating income was -17,933,800 USD and net income was -17,934,200 USD.
Operating cash flow was -12,073,500 USD.
Get free Vistagen Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,089,500 USD
- Operating income
- -17,933,800 USD
- Net income
- -17,934,200 USD
- Operating cash flow
- -12,073,500 USD
Explore related company data
View all 2021 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Vistagen Therapeutics, Inc. financial years